Finasteride - Polichem

Drug Profile

Finasteride - Polichem

Alternative Names: P-3074

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Polichem
  • Developer Almirall S.A.; Polichem
  • Class Androstenes; Antiacnes; Antiandrogens; Antineoplastics; Azasteroids; Small molecules
  • Mechanism of Action Cholestenone 5-alpha reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Alopecia

Most Recent Events

  • 01 Jul 2016 Polichem completes a phase I trial in Healthy volunteers in United Kingdom (Topical) (NCT02791243)
  • 27 May 2016 Phase-III clinical trials in Alopecia in Spain, Hungary (Topical) (EudraCT2015-002877-40)
  • 01 Apr 2016 Phase-I clinical trials in Alopecia (In volunteers) in United Kingdom (Topical) (NCT02791243)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top